Kenneth Pienta is Chief Medical Officer at Cue Biopharma, Inc. (CUE). They have made 6 open-market trades across 2 companies since 2013, most recently 2021-03-16.
CIK 0001571862
4 open-market purchases totalling $159K since 2013, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CUE | SELL | 2021-03-15 | 2021-03-17 | $15.10 | $203K | -19.4% | -7.6% | -5.1% |
| CUE | SELL | 2021-02-16 | 2021-02-18 | $15.12 | $371K | -5.9% | +1.8% | -0.3% |
| CUE | SELL · 10b5-1 | 2021-01-20 | 2021-02-18 | $15.07 | $41K | -5.9% | +1.8% | -0.3% |
| CUE | BUY | 2021-01-20 | 2021-01-22 | $15.07 | $41K | -1.8% | -12.9% | -17.4% |
| CUE | BUY | 2017-12-27 | 2018-01-19 | $7.50 | $15K | +4.5% | +1.5% | -8.2% |
| CRIS | BUY | 2013-11-08 | 2013-11-08 | $2.95 | $59K | -33.2% | -3.5% | -3.5% |
| CRIS | BUY | 2013-09-16 | 2013-11-08 | $4.37 | $44K | -33.2% | -3.5% | -3.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.